WE MOVE
204 West 84th Street
New York, NY 10024
E-mail: wemove@wemove.org
wemove.org • mdvu.org

Stay Connected Research News Chat Discussion Forum Advocacy and Support Organizations Patient Meeting Calendar Movement Disorder Glossary Movement Disorders Virtual University Linkage Library
WE MOVE

E-MOVE Research News

Subject: Sydenham's chorea and chorea gravidarum (AAN report)

Date: 4/23/1999

Successful treatment of Sydenham's chorea with intravenous immunoglobulin: Two cases 
AC May, T Koch 
Neurology 1999;52(Suppl 2):A52 
 
Intravenous immunoglobulin (IVIg) may speed recovery of Sydenham's chorea (SC), according to this report. Two girls, ages 7 and 10, were treated with 2 gm/kg IVIg for SC after failing treatment with valproate, and valproate and pimizide, respectively. Both children experienced rapid, sustained improvement following IVIg. 
 
 
 
Chorea gravidarum: New lessons from an old disease 
F Cardoso, AP Vargas, MCQ Cunningham, SV Amaral, AA Guerra, B Horizonte 
Neurology 1999;52(Suppl 2):A121 
 
Chorea gravidarum (CG) is not caused by an acute infection or autoimmune response, but is related to prior Sydenham's chorea or rheumatic fever, according to this study. Of 129 patients with chorea seen at a single Brazilian movement disorders clinic over a five-year period, 5 were diagnosed with CG. Median age of onset was 18 years, and gestational progression was 10 weeks. History of previous SC was positive in two patients. Evidence of rheumatic valvulopathy was seen in 4 patients, while the fifth had a family history of CG.